STEPHEN ARTHURS: Open Payments
NPI 1437190972 · KINGFISHER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 64 payments from 23 companies in 2025. Trend: 2023 $764 · 2024 $1,036 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Amgen Inc. | 4 | $60 |
| Exact Sciences Corporation | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
Products named: Kerendia, REXULTI, Auvelity, GVOKE HYPOPEN, FANAPT, UBRELVY, VRAYLAR, FARXIGA.
Industry payments across OK — which companies pay providers there.
